Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
459.81
-0.20 (-0.04%)
At close: Oct 15, 2026, 4:00 PM EDT
461.69
+1.88 (0.41%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Madrigal Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 19 analysts polled by S&P Global, Madrigal Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $685.78. The average 1-year stock price forecast is 49.14% higher than the current stock price, while the lowest is $543 (+18.09%) and the highest is $962 (+109.22%).
Price Target: $685.78 (+49.14%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Madrigal Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 12 | 13 | 15 | 15 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 17 | 17 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $669 → $735 | Buy | Maintains | $669 → $735 | +59.85% | Oct 14, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $685 | Buy | Maintains | $685 | +48.97% | Oct 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $620 | Buy | Reiterates | $620 | +34.84% | Oct 9, 2026 |
| Barclays | Barclays | Buy Maintains $962 | Buy | Maintains | $962 | +109.22% | Sep 30, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $704 | Buy | Initiates | $704 | +53.11% | Sep 24, 2026 |
Financial Forecast
Revenue This Year
1.53B
from 958.40M
Increased by 59.57%
Revenue Next Year
2.12B
from 1.53B
Increased by 38.84%
EPS This Year
-6.49
from -12.73
EPS Next Year
9.63
from -6.49
EPS and Forward PE are based on non-GAAP adjusted numbers.